Boston Scientific Corporation (NYSE:BSX) is listed among 13 Best Long Term Low Risk Stocks to Buy Now. Truist cut its price target on BSX to $95 from $120 but maintained a Buy rating after earnings pullback. The reaction followed weaker-than-expected results in the electrophysiology business, causing concerns about growth momentum. Sales of the Watchman device were also slightly below forecasts, mainly due to softer demand in the US market. Boston Scientific forecasts adjusted earnings per share slightly below Wall Street expectations. The company expects organic revenue growth to slow in 2026 compared to 2025. BSX develops and sells medical devices globally. While BSX has investment potential, some AI stocks offer greater upside potential with less downside risk. See our report on the best short-term AI stock.

Read more at Yahoo Finance: Truist Cuts Boston Scientific Corporation (BSX) Price Target but Maintains Buy After Earnings Pullback